HaDEA has published the EU4Health Prior Information Notice HADEA/2025/CPN/0008-PIN - Multiple sourcing Framework Contracts to speed up the development of and access to innovative medical countermeasures – Next-Generation Influenza Vaccines.
This call for tenders will aim to speed up the development of next generation influenza vaccines that could be produced in rapidly scalable manufacturing platforms (e.g. nucleic acid approaches and/or production in scalable eukaryotic or bacterial cell culture, in plants or via المختبر transcription), could support products utilising novel administration routes (e.g. nasal, oral or through microneedle patches), confer mucosal immunity, target potentially pandemic influenza A viruses or could be rapidly adapted to pandemic influenza A viruses, which are protective across influenza subtypes or across alpha-influenza viruses, and/or possess intrinsic immunogenicity without the addition of adjuvants.
Estimated budget: €147 951 410 (indicative ceiling for each of the framework contracts to be signed)
This action supports the policy priority to enhance the availability and accessibility of medical countermeasures and critical medicines, to support innovation and access regarding such products and to ultimately enhance preparedness for future health emergencies in synergy with Horizon أوروبا. It implements the EU4Health Programme’s general objective of improving the availability, accessibility and affordability of medicinal products and medical devices and crisis-relevant products (Article 3, point (c), of Regulation (EU) 2021/522) through the specific objectives defined in Article 4, points (b) and (c), of Regulation (EU) 2021/522.
يتم دعوة الأطراف المهتمة للتحقق من بوابة التمويل والمناقصات for the indicative publication of the call in April 2025.
خلفيّة
EU4Health يُعد برنامج "الاتحاد الأوروبي للصحة" رابع وأكبر برامج الاتحاد الأوروبي الصحية. يتجاوز برنامج "الاتحاد الأوروبي للصحة" مجرد استجابة طموحة لأزمة كوفيد-4، ليشمل تعزيز مرونة أنظمة الرعاية الصحية الأوروبية. يوفر البرنامج التمويل للسلطات الوطنية والمنظمات الصحية وغيرها من الهيئات من خلال المنح والمشتريات العامة، مما يُسهم في تعزيز صحة أوروبا.
